bluebird bio, Inc. Marketable Securities
bluebird bio, Inc. had Marketable Securities of $8.95 million as of 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2023-11-07
- 2023-09-30: Marketable Securities $8.95M.
- 2023-06-30: Marketable Securities $72.43M.
- 2023-03-31: Marketable Securities $79.21M.
- 2022-12-31: Marketable Securities $68.73M.
| Period end | Marketable Securities | Marketable Securities as first filed |
|---|---|---|
| 2023-09-30 | $8.95M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $72.43M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $79.21M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $68.73M 10-Q · filed 2023-11-07 | |
| 2022-09-30 | $74.56M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $91.65M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $160.38M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $235.46M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $568.27M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $588.16M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $653.84M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $481.04M 10-K · filed 2022-03-04 | $956.44M 10-K · filed 2021-02-23 |
| 2020-09-30 | $1.11B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $400.02M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $671.73M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $910.75M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $1.11B 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $1.26B 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $1.51B 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $1.49B 10-K · filed 2020-02-18 | |
| 2017-12-31 | $855.80M 10-K · filed 2019-02-21 | |
| 2013-12-31 | $0.00 10-K · filed 2014-03-05 |